齐齐哈尔医学院学报
齊齊哈爾醫學院學報
제제합이의학원학보
Journal of Qiqihar University of Medicine
2015年
32期
4914-4915,4916
,共3页
变异性心绞痛%临床治疗%心电图
變異性心絞痛%臨床治療%心電圖
변이성심교통%림상치료%심전도
Variant angina%Clinical treatment%Electrocardiogram
目的：通过单硝酸异山梨酯缓释胶囊联合盐酸地尔硫卓片对变异性心绞痛患者的临床疗效分析；探讨其对变异性心绞痛患者的治疗作用。方法选择我院2005年6月至2015年6月确诊的变异性心绞痛患者60例为研究对象，随机分为两组，分别是：观察组（变异性心绞痛患者）：30名，年龄（66．78±14．65）岁，服用单硝酸异山梨酯缓释胶囊联合盐酸地尔硫卓片；对照组（变异性心绞痛患者）：30名年龄（68．85±12．39）岁；服用美托洛尔缓释片。随访1月，观察两组患者治疗前后症状发作情况，包括：心绞痛发作次数、胸痛持续时间、缓解时间以及心电图改善情况。结果两组患者治疗前后比较，心绞痛发作次数、胸痛持续时间、缓解时间以及心电图改善情况均有明显改善，差异有统计学意义，P＜0．05。其中，观察组患者较对照组在心绞痛发作次数、胸痛持续时间、缓解时间、以及心电图改善情况有明显优势；且临床疗效优于对照组；差异有统计学意义，P＜0．05。结论单硝酸异山梨酯缓释胶囊联合盐酸地尔硫卓片对变异性心绞痛患者具有明显控制心绞痛发作的治疗作用。
目的：通過單硝痠異山梨酯緩釋膠囊聯閤鹽痠地爾硫卓片對變異性心絞痛患者的臨床療效分析；探討其對變異性心絞痛患者的治療作用。方法選擇我院2005年6月至2015年6月確診的變異性心絞痛患者60例為研究對象，隨機分為兩組，分彆是：觀察組（變異性心絞痛患者）：30名，年齡（66．78±14．65）歲，服用單硝痠異山梨酯緩釋膠囊聯閤鹽痠地爾硫卓片；對照組（變異性心絞痛患者）：30名年齡（68．85±12．39）歲；服用美託洛爾緩釋片。隨訪1月，觀察兩組患者治療前後癥狀髮作情況，包括：心絞痛髮作次數、胸痛持續時間、緩解時間以及心電圖改善情況。結果兩組患者治療前後比較，心絞痛髮作次數、胸痛持續時間、緩解時間以及心電圖改善情況均有明顯改善，差異有統計學意義，P＜0．05。其中，觀察組患者較對照組在心絞痛髮作次數、胸痛持續時間、緩解時間、以及心電圖改善情況有明顯優勢；且臨床療效優于對照組；差異有統計學意義，P＜0．05。結論單硝痠異山梨酯緩釋膠囊聯閤鹽痠地爾硫卓片對變異性心絞痛患者具有明顯控製心絞痛髮作的治療作用。
목적：통과단초산이산리지완석효낭연합염산지이류탁편대변이성심교통환자적림상료효분석；탐토기대변이성심교통환자적치료작용。방법선택아원2005년6월지2015년6월학진적변이성심교통환자60례위연구대상，수궤분위량조，분별시：관찰조（변이성심교통환자）：30명，년령（66．78±14．65）세，복용단초산이산리지완석효낭연합염산지이류탁편；대조조（변이성심교통환자）：30명년령（68．85±12．39）세；복용미탁락이완석편。수방1월，관찰량조환자치료전후증상발작정황，포괄：심교통발작차수、흉통지속시간、완해시간이급심전도개선정황。결과량조환자치료전후비교，심교통발작차수、흉통지속시간、완해시간이급심전도개선정황균유명현개선，차이유통계학의의，P＜0．05。기중，관찰조환자교대조조재심교통발작차수、흉통지속시간、완해시간、이급심전도개선정황유명현우세；차림상료효우우대조조；차이유통계학의의，P＜0．05。결론단초산이산리지완석효낭연합염산지이류탁편대변이성심교통환자구유명현공제심교통발작적치료작용。
Objective To investigate the clinical effect through Isosorbide Mononitrate Sustained Release Capsules combined with Diltiazem Hydrochloride in treatment of patients with variant angina .Methods 60 cases patients were chosen as the research object whom diagnosed with variant angina in our hospital from June 2005 to June 2015 and randomly assigned into two groups:The observation group:30cases, age:(66.78 ±14.65)years, taking Isosorbide Mononitrate Sustained Release Capsules combined with Diltiazem Hydrochloride tablets ;control group:30 cases, age:(68.85 ±12.39)years, taking metoprolol tartrate sustained release tablet .After following up 1month, two groups of the patients were observed before and after treatment symptoms , including:the number of angina attacks , the duration of chest pain , the remission time , and the improvement of ECG .Results Compared two groups of patients before and after treatment , angina attack frequency , duration of chest pain , relieve time, and electrocardiogram (ECG) were significantly improved, the difference is significant (P<0.05). Among them, the observation group compared with those of control group in angina attack frequency , chest pain duration, remission time, and electrocardiogram ( ECG) has obvious advantages; and clinical curative effect is better than that of the control group;difference was significant (P<0.05).Conclusions Isosorbide Mononitrate Sustained Release Capsules combined with Diltiazem Hydrochloride of obvious treatment effect to control angina attack of patients with variant angina .
